Top Gap Ups and Downs on Thursday: SAP, AZN, ADBE and More
Alcon to Host 2025 Capital Markets Day
Is It the Right Time to Hold Alcon Stock in Your Portfolio Now?
U.S. Contact Lenses Market Size and Share Analysis 2025-2033, Featuring Bausch & Lomb, Alcon, Carl Zeiss Meditec, The Cooper Companies, Hoya Corporation & More
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $112.3
Alcon (ALC) Gets a Buy From RBC Capital
Deutsche Bank Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $103.26
Stocks That Could Be Safe From Tariffs Risk Compared to Their Industry Peers
UBS Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $111.63
Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alcon (ALC) and Cooper Co (COO)
Alcon Stock Gains From Innovation Despite Macroeconomic Troubles
J.P. Morgan Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $105.88
Alcon's Earnings Call: Record Sales & Strategic Growth
Alcon Canada Strengthens Its Commitment to Astigmatic Patients With TOTAL30 for Astigmatism Expanded Parameters
Baird Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $108
Stifel Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $100
A Quick Look at Today's Ratings for Alcon(ALC.US), With a Forecast Between $91.6 to $107
Baird Maintains Outperform on Alcon, Raises Price Target to $108
Analysts Conflicted on These Healthcare Names: Agilon Health (AGL), AN2 Therapeutics, Inc. (ANTX) and Alcon (ALC)
Alcon Full Year 2024 Earnings: EPS Beats Expectations